Back
  1. Home
  2. Profile of Hélène Brossel (ULiège)
Profil

Brossel Hélène

See author's contact details
Main Referenced Co-authors
Willems, Luc  (7)
Hamaïdia, Malik  (5)
Fontaine, Alexis  (4)
Hoyos, Clotilde  (4)
Jamakhani, Majeed  (4)
Main Referenced Keywords
chemotherapy (2); eosinophils (2); mesothelioma (2); Animals (1); BLV (1);
Main Referenced Disciplines
Oncology (8)
Immunology & infectious disease (1)
Veterinary medicine & animal health (1)

Publications (total 9)

The most downloaded
145 downloads
Brossel, H. (2023). RNA interference of the E3 ubiquitin ligase RAD18 promotes senescence and reduces tumor growth in pleural mesothelioma [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/301715 https://hdl.handle.net/2268/301715

The most cited

72 citations (Scopus®)

Pötgens, S. A., Brossel, H., Sboarina, M., Catry, E., Cani, P. D., Neyrinck, A. M., Delzenne, N. M., & Bindels, L. B. (17 August 2018). Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction. Scientific Reports, 8 (1), 12321. doi:10.1038/s41598-018-30569-5 https://hdl.handle.net/2268/247784

Brossel, H. (2023). RNA interference of the E3 ubiquitin ligase RAD18 promotes senescence and reduces tumor growth in pleural mesothelioma [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/301715

Willems, M., Scherpereel, A., Wasielewski, E., Raskin, J., Brossel, H., Fontaine, A., Grégoire, M., Halkin, L., Jamakhani, M., Heinen, V., Louis, R., Duysinx, B., Hamaïdia, M.* , & Willems, L.*. (2023). Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma. Frontiers in Immunology, 14, 1148798. doi:10.3389/fimmu.2023.1148798
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Hoyos, C., Fontaine, A., Brossel, H., Willems, M., Jamakhani, M., Vandermeers, F., Safari, R., HEINEN, V., LOUIS, R., DUYSINX, B., Scherpereel, A., Wasielewski, E., Mascaux, C., Hamaïdia, M.* , & Willems, L.*. (14 December 2021). Contribution of lysine deacetylases to the therapy of malignant pleural mesothelioma [Poster presentation]. Giga Cancer Day, Liège, Belgium.
* These authors have contributed equally to this work.

Willems, M., Jamakhani, M., Scherpereel, A., Wasielewski, E., Brossel, H., Fontaine, A., Hoyos, C., Grégoire, M., Louis, R., Duysinx, B., Hamaïdia, M.* , & Willems, L.*. (14 December 2021). Eosinophils inhibit malignant pleural mesothelioma response to chemotherapy [Poster presentation]. GIGA-Cancer Day, Liège, Belgium.
* These authors have contributed equally to this work.

Brossel, H., Fontaine, A., Hoyos, C., Jamakhani, M., Willems, M., Hamaïdia, M., & Willems, L. (2021). Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of Mesothelioma. Cancers, 13, 3211. doi:10.3390/cancers13133211
Peer Reviewed verified by ORBi

Brossel, H., Vikas, Y., & Willems, L. (November 2019). Régulation ubiquitine-dépendante des voies de tolérance aux dommages à l’ADN dans le cadre du mésothéliome pleural malin [Poster presentation]. 2èmes journées francophones sur le mésothéliome, Nantes, France.

Brossel, H., Vikas, Y., & Willems, L. (November 2019). Régulation des voies de tolérance aux dommages à l’ADN par la E3 ubiquitine ligase RAD18: Mécanismes et perspectives thérapeutiques dans le cadre du mésothéliome pleural malin [Paper presentation]. 2èmes journées francophones sur le mésothéliome, Nantes, France.

Abdala, A., Alvarez, I., Brossel, H., Calvinho, L., Carignano, H., Franco, L., Gazon, H., Gillissen, C., Hamaïdia, M., Hoyos, C., Jacques, J.-R., Joris, T., Laval, F., Petersen, M., Porquet, F., Porta, N., Ruiz, V., Safari, R., Suárez Archilla, G., ... Willems, L. (2019). BLV: lessons on vaccine development. Retrovirology, 2019 (16), 26. doi:10.1186/s12977-019-0488-8
Peer Reviewed verified by ORBi

Pötgens, S. A., Brossel, H., Sboarina, M., Catry, E., Cani, P. D., Neyrinck, A. M., Delzenne, N. M., & Bindels, L. B. (17 August 2018). Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction. Scientific Reports, 8 (1), 12321. doi:10.1038/s41598-018-30569-5
Peer Reviewed verified by ORBi

Contact ORBi